Physician profile
David E E Holck
NPI 1548319601
$7,111.51
in general payments reported to CMS, 2019-2025
19 companies · $1,433 in 2025
The $1,433 reported for 2025 was more than what 81% of Ophthalmic Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $299).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2020: $244 · 2021: $577 · 2022: $2,472 · 2023: $962 · 2024: $1,179 · 2025: $1,433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,573.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $2,657.26 | 2020-2023 | Tepezza |
| Amgen INC. | $1,183.19 | 2024-2025 | Tepezza |
| Biotissue Holdings INC. | $1,043.86 | 2019-2025 | |
| Abbvie INC. | $839.22 | 2022-2025 | |
| Alcon Vision LLC | $279.34 | 2022-2025 | Clareon |
| Allergan, INC. | $139.70 | 2019-2022 | |
| Eyevance Pharmaceuticals LLC | $124.99 | 2021 | |
| Dompe US, INC. | $121.85 | 2024 | Oxervate |
| Ocular Therapeutix, INC. | $107.14 | 2022 | |
| Nova Eye, INC. | $105.13 | 2025 | |
| Rxsight INC | $101.10 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $100.00 | 2019 | |
| Aerie Pharmaceuticals, INC. | $98.24 | 2020 | |
| Merz Pharmaceuticals, LLC | $89.98 | 2021-2024 | Xeomin |
| Boston Scientific Corporation | $59.75 | 2023-2025 | Wavewriter Alpha Prime 16 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $24.57 | 2025 | Tyrvaya |
| Galderma Laboratories, L.P. | $14.33 | 2022 | |
| Merz North America, INC. | $11.51 | 2019 | |
| Kerecis Limited | $10.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Holck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.